Unleashing the Power of OpenAI in Shaping the Future of Cancer Research
Artificial intelligence (AI) is rapidly changing cancer research and treatment development. OpenAI, a pioneer in AI research, is at the vanguard of this revolution. This review article highlights the potential of OpenAI to shape the future of cancer research, including the identification of new ther...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
QAASPA Publisher,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_d19f137f86dc4f62b4fc7f8ff961cfad | ||
042 | |a dc | ||
100 | 1 | 0 | |a Ramyar M. Abdullah |e author |
700 | 1 | 0 | |a Hawro D. I. Masseh |e author |
700 | 1 | 0 | |a Abbas Salihi |e author |
700 | 1 | 0 | |a Bawar Mohammed Faraj |e author |
245 | 0 | 0 | |a Unleashing the Power of OpenAI in Shaping the Future of Cancer Research |
260 | |b QAASPA Publisher, |c 2023-06-01T00:00:00Z. | ||
500 | |a 2960-1428 | ||
500 | |a 10.59786/bmtj.112 | ||
520 | |a Artificial intelligence (AI) is rapidly changing cancer research and treatment development. OpenAI, a pioneer in AI research, is at the vanguard of this revolution. This review article highlights the potential of OpenAI to shape the future of cancer research, including the identification of new therapeutic targets, predictive modeling for cancer progression and response to therapy, the development of personalized treatment plans, and advancements in drug discovery and development. The article also discusses the challenges of implementing OpenAI in cancer research and incorporating AI into the research process. Finally, the article concludes with a discussion of AI's future prospects in cancer research, as well as future research recommendations. | ||
546 | |a EN | ||
690 | |a openai | ||
690 | |a cancer research | ||
690 | |a Medicine (General) | ||
690 | |a R5-920 | ||
690 | |a Gynecology and obstetrics | ||
690 | |a RG1-991 | ||
690 | |a Dermatology | ||
690 | |a RL1-803 | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
690 | |a Nursing | ||
690 | |a RT1-120 | ||
690 | |a Biology (General) | ||
690 | |a QH301-705.5 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n BioMed Target Journal, Vol 1, Iss 1, Pp 2-11 (2023) | |
787 | 0 | |n https://qaaspa.com/index.php/bmtj/article/view/3 | |
787 | 0 | |n https://doaj.org/toc/2960-1428 | |
856 | 4 | 1 | |u https://doaj.org/article/d19f137f86dc4f62b4fc7f8ff961cfad |z Connect to this object online. |